Empagliflozin after Acute Myocardial Infarction
- DOI
- 10.1056/nejmoa2314051
- Published
- 2024-04-25
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2314051,
title = {Empagliflozin after Acute Myocardial Infarction},
author = {Javed Butler and W. Schuyler Jones and Jacob A. Udell and Stefan D. Anker and Mark C. Petrie and Josephine Harrington and Michaela Mattheus and Isabella Zwiener and Offer Amir and M. Cecilia Bahit and Johann Bauersachs and Antoni Bayes-Genis and Yundai Chen and Vijay K. Chopra and Gemma Figtree and Junbo Ge and Shaun G. Goodman and Nina Gotcheva and Shinya Goto and Tomasz Gasior and Waheed Jamal and James L. Januzzi and Myung Ho Jeong and Yuri Lopatin and Renato D. Lopes and Béla Merkely and Puja B. Parikh and Alexander Parkhomenko and Piotr Ponikowski and Xavier Rossello and Morten Schou and Dragan Simic and P. Gabriel Steg and Joanna Szachniewicz and Peter van der Meer and Dragos Vinereanu and Shelley Zieroth and Martina Brueckmann and Mikhail Sumin and Deepak L. Bhatt and Adrian F. Hernandez},
year = {2024},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2314051},
url = {https://doi.org/10.1056/nejmoa2314051}
}RIS
TY - JOUR TI - Empagliflozin after Acute Myocardial Infarction AU - Javed Butler AU - W. Schuyler Jones AU - Jacob A. Udell AU - Stefan D. Anker AU - Mark C. Petrie AU - Josephine Harrington AU - Michaela Mattheus AU - Isabella Zwiener AU - Offer Amir AU - M. Cecilia Bahit AU - Johann Bauersachs AU - Antoni Bayes-Genis AU - Yundai Chen AU - Vijay K. Chopra AU - Gemma Figtree AU - Junbo Ge AU - Shaun G. Goodman AU - Nina Gotcheva AU - Shinya Goto AU - Tomasz Gasior AU - Waheed Jamal AU - James L. Januzzi AU - Myung Ho Jeong AU - Yuri Lopatin AU - Renato D. Lopes AU - Béla Merkely AU - Puja B. Parikh AU - Alexander Parkhomenko AU - Piotr Ponikowski AU - Xavier Rossello AU - Morten Schou AU - Dragan Simic AU - P. Gabriel Steg AU - Joanna Szachniewicz AU - Peter van der Meer AU - Dragos Vinereanu AU - Shelley Zieroth AU - Martina Brueckmann AU - Mikhail Sumin AU - Deepak L. Bhatt AU - Adrian F. Hernandez PY - 2024 JO - New England Journal of Medicine DO - 10.1056/nejmoa2314051 UR - https://doi.org/10.1056/nejmoa2314051 ER -
APA
Butler, J., Jones, W. S., Udell, J. A., Anker, S. D., Petrie, M. C., Harrington, J., Mattheus, M., Zwiener, I., Amir, O., Bahit, M. C., Bauersachs, J., Bayes-Genis, A., Chen, Y., Chopra, V. K., Figtree, G., Ge, J., Goodman, S. G., Gotcheva, N., Goto, S., Gasior, T., Jamal, W., Januzzi, J. L., Jeong, M. H., Lopatin, Y., Lopes, R. D., Merkely, B., Parikh, P. B., Parkhomenko, A., Ponikowski, P., Rossello, X., Schou, M., Simic, D., Steg, P. G., Szachniewicz, J., Meer, P. V. D., Vinereanu, D., Zieroth, S., Brueckmann, M., Sumin, M., Bhatt, D. L., & Hernandez, A. F. (2024). Empagliflozin after Acute Myocardial Infarction. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2314051
Source records
- crossref · retrieved 2026-09-26T19:57:43.510Z